Clinical trial
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With…
NCT00003410 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003410 |
|---|---|
| Title | Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas |
| Official title | Pilot Trial of Gadolium Texaphyrin for Magnetic Resonance Imaging-Guided Resection of High Grade Gliomas |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure |
| Interventions | motexafin gadolinium, magnetic resonance imaging, surgical procedure |
| Start date | Jul 1, 1998 |
| Completion | Jun 1, 2004 |
| First posted | Jun 9, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: